Literature DB >> 10843282

Clinicopathologic study of mass-screened neuroblastoma with special emphasis on untreated observed cases: a possible histologic clue to tumor regression.

R Ijiri1, Y Tanaka, K Kato, K Misugi, H Nishihira, Y Toyoda, H Kigasawa, T Nishi, M Takeuchi, N Aida, T Momoi.   

Abstract

Spontaneous regression and maturation of neuroblastoma (NB) are well documented and occur frequently in infants, including those detected by mass screening. To seek histologic clues for regression/maturation in mass-screened NB, clinicopathologic features of 12 tumors that were resected after 2 to 18 months of untreated observation were reviewed. Unobserved screened and age-matched unscreened patients were also studied. To evaluate the possible important role of apoptosis, apoptotic cells were detected by in situ deoxyribonucleic acid (DNA) nick end labeling and immunohistochemical stain for activated caspase-3. Nests with a varying degree of reduced cellularity ("less cellular" and "hypocellular" nests) were common in patients younger than 18 months of age, and were rare in older patients. Two characteristic cells, which have not been focused previously, were frequent, especially in the hypocellular nests. One showed amorphic eosinophilic cytoplasm with pyknotic nuclei and the other contained plump cytoplasm with well-maintained nuclei. These cells were also observed in 89% of the unobserved screened NBs and 79% of the age-matched unscreened patients with good outcome, whereas they could not be confirmed in any of the age-matched unscreened NBs with poor outcome. The amorphic and plump cells were negative for activated caspase-3 and in situ DNA nick end labeling. From these results, the authors hypothesize that these cells most likely represent a degenerative process, in either a state before the activation of caspase-3 or a caspase-independent form of cell death. The presence of less cellular and hypocellular nests with amorphic/plump cells may serve as one of the important clues in predicting tumor prognosis.

Entities:  

Mesh:

Year:  2000        PMID: 10843282     DOI: 10.1097/00000478-200006000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

1.  Calreticulin Regulates VEGF-A in Neuroblastoma Cells.

Authors:  Wen-Chin Weng; Kuan-Hung Lin; Pei-Yi Wu; Yi-Chien Lu; Yi-Cheng Weng; Bo-Jeng Wang; Yung-Feng Liao; Wen-Ming Hsu; Wang-Tso Lee; Hsinyu Lee
Journal:  Mol Neurobiol       Date:  2014-10-07       Impact factor: 5.590

Review 2.  Functional roles of calreticulin in cancer biology.

Authors:  Yi-Chien Lu; Wen-Chin Weng; Hsinyu Lee
Journal:  Biomed Res Int       Date:  2015-03-31       Impact factor: 3.411

3.  Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma.

Authors:  Pei-Yi Wu; Yung-Feng Liao; Hsueh-Fen Juan; Hsuan-Cheng Huang; Bo-Jeng Wang; Yen-Lin Lu; I-Shing Yu; Yu-Yin Shih; Yung-Ming Jeng; Wen-Ming Hsu; Hsinyu Lee
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

4.  VEGF expression correlates with neuronal differentiation and predicts a favorable prognosis in patients with neuroblastoma.

Authors:  Wen-Chin Weng; Kuan-Hung Lin; Pei-Yi Wu; Ya-Hsuan Ho; Yen-Lin Liu; Bo-Jeng Wang; Chien-Chin Chen; Yueh-Chien Lin; Yung-Feng Liao; Wang-Tso Lee; Wen-Ming Hsu; Hsinyu Lee
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.